Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
27.5M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
-248K
-
Total reported value, excl. options
-
$81.6M
-
Value change
-
-$1.52M
-
Number of buys
-
29
-
Number of sells
-
-22
-
Price
-
$6.09
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q1 2025
71 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value as of Q1 2025.
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
of 27.5M outstanding shares and own 48.78% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Solas Capital Management, LLC (2.25M shares), Rosalind Advisors, Inc. (1.78M shares), BlackRock, Inc. (1.25M shares), VANGUARD GROUP INC (965K shares), HARBERT FUND ADVISORS, INC. (467K shares), AIGH Capital Management LLC (361K shares), STATE STREET CORP (338K shares), GEODE CAPITAL MANAGEMENT, LLC (311K shares), and MORGAN STANLEY (297K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.